The IMA (Investment Management Association) commissioned CRA to undertake an independent appraisal of both the potential impact of the FSA’s proposals set out in CP1761 and the cost-benefit analysis undertaken for the FSA by OXERA2. In particular, CRA was asked to examine in more detail: how these proposals might be implemented in practice; how the detail of their rules could affect the market outcome; and whether there were alternative proposals also worthy of further consideration.
Were shareholders harmed by Senate Bill 21’s amendments to the Delaware General Corporation Law?
Delaware Governor Meyer signed into law Senate Bill 21 (SB21) in March 2025, updating Delaware’s corporate law, with some of the key provisions including safe...